Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bally's (BALY) Cash & Equivalents (2018 - 2025)

Bally's (BALY) has disclosed Cash & Equivalents for 8 consecutive years, with $798.4 million as the latest value for Q4 2025.

  • For Q4 2025, Cash & Equivalents rose 366.28% year-over-year to $798.4 million; the TTM value through Dec 2025 reached $798.4 million, up 366.28%, while the annual FY2025 figure was $798.4 million, 366.28% up from the prior year.
  • Cash & Equivalents was $798.4 million for Q4 2025 at Bally's, up from $160.7 million in the prior quarter.
  • The five-year high for Cash & Equivalents was $798.4 million in Q4 2025, with the low at $151.7 million in Q1 2021.
  • Historically, Cash & Equivalents has averaged $216.6 million across 5 years, with a median of $175.4 million in 2022.
  • The largest annual shift saw Cash & Equivalents tumbled 58.06% in 2021 before it soared 366.28% in 2025.
  • Over 5 years, Cash & Equivalents stood at $206.2 million in 2021, then rose by 3.07% to $212.5 million in 2022, then decreased by 23.21% to $163.2 million in 2023, then increased by 4.93% to $171.2 million in 2024, then soared by 366.28% to $798.4 million in 2025.
  • Per Business Quant database, its latest 3 readings for Cash & Equivalents were $798.4 million in Q4 2025, $160.7 million in Q3 2025, and $174.6 million in Q2 2025.